Traduction de «profit direct par produit » (Français → Anglais) :

direct product profit | DPP | direct product profitability

gains [ non-operating income | non-operating revenue ]

Therapeutic Products Directorate [ TPD | Therapeutic Products Programme | Drugs and Medical Devices Directorate | Drugs and Medical Devices Programme | Drugs Directorate ]

gains | non-operating income | non-operating revenue

Commercial Chemicals Evaluation Branch [ CCEB | Commercial Chemicals Branch ]

paid direct to the EPO

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include self-report data, analysis of blood and other body fluids, characteristic physical and psychological symptom ...[+++]s, clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...

Directive 2010/30/EU on the indication by labelling and standard product information of the consumption of energy and other resources by energy-related products | Energy Labelling Directive

Directive 2009/28/EC of the European Parliament and of the Council of 23 April 2009 on the promotion of the use of energy from renewable sources and amending and subsequently repealing Directives 2001/77/EC and 2003/30/EC | Directive on the promotion of the use of energy from renewable sources | Renewable Energy Directive | Renewables Directive | RED [Abbr.]

unusual result | special result | exceptional result | non-recurring result | unusual gains and charges | special gains and charges | unusual gains and losses | special gains and losses | exceptional gains and losses | special profits and losses | special charges and income

Privacy-compliant products are products developed in full compliance with the Directive, privacy-friendly products go one step further by introducing some elements that make the privacy aspects more easily-accessible to the users like for instance by providing very user-friendly information to the data subject or very easy ways of exercising their rights.

According to the case-law, a charge which is imposed on domestic and imported products according to the same criteria may nevertheless be prohibited by the Treaty if the revenue from such a charge is intended to support activities which specifically benefit the taxed domestic products.

Following this review, and considering, in particular, the experience related to the extended scope of this Directive, the Commission shall assess, notably, the appropriateness of extending the scope of the Directive to non-energy-related products, in order to significantly reduce environmental impacts throughout such products’ whole life cycle, after consultation of the Consultation Forum referred to in Article 18, and shall, as appropriate, present proposals to the European Parliament and th ...[+++]e Council for amending this Directive.

Following this review, and considering, in particular, the experience related to the extended scope of this Directive, the Commission shall assess, notably, the appropriateness of extending the scope of the Directive to non-energy-related products, in order to significantly reduce environmental impacts throughout such products’ whole life cycle, after consultation of the Consultation Forum referred to in Article 18, and shall, as appropriate, present proposals to the European Parliament and th ...[+++]e Council for amending this Directive.